Daclatasvir and asunaprevir in hemodialysis patients with hepatitis C virus infection: a nationwide retrospective study in Japan

被引:0
|
作者
Goki Suda
Norihiro Furusyo
Hidenori Toyoda
Yoshiiku Kawakami
Hiroki Ikeda
Michihiro Suzuki
Keiko Arataki
Nami Mori
Keiji Tsuji
Yoshio Katamura
Koichi Takaguchi
Toru Ishikawa
Kunihiko Tsuji
Noritomo Shimada
Atsushi Hiraoka
Sho Yamsaki
Masato Nakai
Takuya Sho
Kenichi Morikawa
Koji Ogawa
Mineo Kudo
Atsushi Nagasaka
Ken Furuya
Yoshiya Yamamoto
Kanji Kato
Yoshiyuki Ueno
Etsuko Iio
Yasuhito Tanaka
Masayuki Kurosaki
Takashi Kumada
Kazuaki Chayama
Naoya Sakamoto
机构
[1] Hokkaido University,Department of Gastroenterology and Hepatology, Graduate School of Medicine
[2] Kyushu University Hospital,Department of General Internal Medicine
[3] Ogaki Municipal Hospital,Department of Gastroenterology
[4] Hiroshima University,Department of Gastroenterology and Metabolism, Applied Life Science, Institute of Biomedical and Health Science
[5] St. Marianna University School of Medicine,Division of Gastroenterology and Hepatology
[6] Tsuchiya General Hospital,Department of Gastroenterology/Liver Center
[7] Hiroshima Red Cross Hospital and Atomic-Bomb Survivors Hospital,Department of Gastroenterology
[8] Onomichi General Hospital,Department of Hepatology
[9] Kagawa Prefectural Central Hospital,Department of Gastroenterology and Hepatology
[10] Saiseikai Niigata Daini Hospital,Center for Gastroenterology
[11] Teine Keijinkai Hospital,Division of Gastroenterology and Hepatology
[12] Ootakanomori Hospital,Gastroenterology Center
[13] Ehime Prefectural Central Hospital,Department of Gastroenterology and Hepatology
[14] Sapporo Hokuyu Hospital,Department of Gastroenterology, Faculty of Medicine
[15] Sapporo City General Hospital,Department of Gastroenterology and Hepatology
[16] Japan Community Health Care Organization (JCHO) Hokkaido Hospital,undefined
[17] Hakodate City Hospital,undefined
[18] Iwamisawa Manicipal General Hospital,undefined
[19] Yamagata University,undefined
[20] Nagoya City University Graduate School of Medical Sciences,undefined
[21] Musashino Red Cross Hospital,undefined
来源
关键词
Hemodialysis; HCV; DAAs; CKD;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:119 / 128
页数:9
相关论文
共 50 条
  • [41] Daclatasvir plus asunaprevir as interferon-free regimen for recurrent hepatitis C virus infection after liver transplantation: A preliminary study
    Tanaka, Motofumi
    Fukumoto, Takumi
    Kuramitsu, Kaori
    Kido, Masahiro
    Kinoshita, Hisoka
    So, Shinichi
    Yoshida, Toshihiko
    Arai, Keisuke
    Terai, Sachio
    Matsumoto, Taku
    Goto, Tadahiro
    Asari, Sadaki
    Toyama, Hirochika
    Ajiki, Tetsuo
    Ku, Yonson
    TRANSPLANTATION, 2016, 100 (07) : S578 - S578
  • [42] Combination of sofosbuvir and daclatasvir in the treatment of genotype 3 chronic hepatitis C virus infection in patients on maintenance hemodialysis
    Sperl, Jan
    Frankova, Sona
    Kreidlova, Miluse
    Merta, Dusan
    Tothova, Monika
    Spicak, Julius
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2017, 13 : 733 - 738
  • [43] Reactivation of hepatitis B virus during interferon-free therapy with daclatasvir and asunaprevir in patient with hepatitis B virus/hepatitis C virus co-infection
    Takayama, Hiroki
    Sato, Takeshi
    Ikeda, Fusao
    Fujiki, Shigeatsu
    HEPATOLOGY RESEARCH, 2016, 46 (05) : 489 - 491
  • [44] A very high prevalence of hepatitis C virus infection among patients undergoing hemodialysis in Kosovo: a nationwide study
    Xhevat Jakupi
    Jana Mlakar
    Maja M. Lunar
    Katja Seme
    Ibrahim Rudhani
    Lul Raka
    Adriana Vince
    Mario Poljak
    BMC Nephrology, 19
  • [45] A very high prevalence of hepatitis C virus infection among patients undergoing hemodialysis in Kosovo: a nationwide study
    Jakupi, Xhevat
    Mlakar, Jana
    Lunar, Maja M.
    Seme, Katja
    Rudhani, Ibrahim
    Raka, Lul
    Vince, Adriana
    Poljak, Mario
    BMC NEPHROLOGY, 2018, 19
  • [46] Occult Hepatitis B Virus Infection in Hemodialysis Patients in Japan
    Saijo, Tomokatsu
    Joki, Nobuhiko
    Inishi, Yoji
    Muto, Mikako
    Saijo, Motohiko
    Hase, Hiroki
    THERAPEUTIC APHERESIS AND DIALYSIS, 2015, 19 (02) : 125 - 130
  • [47] Beclabuvir in combination with asunaprevir and daclatasvir for hepatitis C virus genotype 1 infection: A systematic review and meta-analysis
    Ahmed, Ali Mahmoud
    Doheim, Mohamed Fahmy
    Mattar, Omar Mohamed
    Sherif, Nourin Ali
    Duy Hieu Truong
    Hoa, Pham T. L.
    Hirayama, Kenji
    Nguyen Tien Huy
    JOURNAL OF MEDICAL VIROLOGY, 2018, 90 (05) : 907 - 918
  • [48] Effective Treatment With Daclatasvir and Asunaprevir in Kidney Transplant Patients Infected With Hepatitis C Virus: A Report of Two Cases
    Koshino, K.
    Ushigome, H.
    Masuda, K.
    Matsuyama, T.
    Harada, S.
    Nakamura, T.
    Nobori, S.
    Lida, T.
    Yoshimura, N.
    TRANSPLANTATION PROCEEDINGS, 2017, 49 (05) : 1053 - 1055
  • [49] Daclatasvir and asunaprevir improves health-related quality of life in Japanese patients infected with hepatitis C virus
    Ikeda, Hiroki
    Watanabe, Tsunamasa
    Matsumoto, Nobuyuki
    Hiraishi, Tetsuya
    Nakano, Hiroyasu
    Noguchi, Yohei
    Hattori, Nobuhiro
    Shigefuku, Ryuta
    Yamashita, Masaki
    Nakahara, Kazunari
    Matsunaga, Kotaro
    Okuse, Chiaki
    Yotsuyanagi, Hiroshi
    Tanaka, Atsushi
    Suzuki, Michihiro
    Itoh, Fumio
    JGH OPEN, 2018, 2 (03): : 87 - 92
  • [50] Virological response to daclatasvir and asunaprevir combination therapy for chronic hepatitis C virus genotype 1b infection in dialysis patients: A prospective, multicenter study
    Uojima H.
    Kobayashi S.
    Hidaka H.
    Matsumoto S.
    Ohtake T.
    Kinbara T.
    Oka M.
    Yamanouchi Y.
    Kunieda T.
    Yamanoue H.
    Kanemaru T.
    Tsutsumi K.
    Fujikawa T.
    Sung J.H.
    Kako M.
    Renal Replacement Therapy, 3 (1)